Intellia Therapeutics (38I) Revenue
Intellia Therapeutics Revenue
Intellia Therapeutics had a revenue of 7.66M in the quarter ending Jun 30, 2026, with -49.10%. This bring the company's revenue in the last twelve months to 59.51M, Decreased 9.96%. In the fiscal year ending Dec 31, 2025, Intellia Therapeutics had annual revenue of 67.67M with 16.92% growth.
- Revenue (ttm)
- 59.51M
- Revenue Growth
- 4.70%
- P/S Ratio
- 23.04
- Revenue/Employee
- EUR 179,499
- Employees
- 377
- Market Cap
- EUR 1.56B
Revenue Chart
Intellia Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 67.67M | 9.79M | 16.92% |
| Dec 31, 2024 | 57.88M | 21.60M | 59.55% |
| Dec 31, 2023 | 36.27M | -15.85M | -30.40% |
| Dec 31, 2022 | 52.12M | 19.07M | 57.69% |
| Dec 31, 2021 | 33.05M | -24.94M | -43.01% |
| Dec 31, 2020 | 57.99M | 14.89M | 34.55% |
| Dec 31, 2019 | 43.10M | 12.67M | 41.63% |
| Dec 31, 2018 | 30.43M | 4.32M | 16.53% |
| Dec 31, 2017 | 26.12M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.